FIELD: medicine.
SUBSTANCE: method involves introducing Capecitabin on the background of preoperational irradiation as radio modifier at a dose of 1650 mg/m2 divided into 2 portions given 2 h before exposure and 12 h after the exposure.
EFFECT: prevented local relapse occurrence; prolonged survival period.
2 dwg, 9 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF COMBINATION TREATMENT OF LOCALLY ADVANCED GASTRIC CANCER | 2011 |
|
RU2478407C1 |
METHOD OF COMBINED TREATMENT OF LOCALLY ADVANCED GASTRIC CANCER | 2020 |
|
RU2725079C2 |
METHOD OF COMBINED TREATMENT OF LOCALLY ADVANCED FORMS OF CANCER OF NASAL CAVITY AND PARANASAL SINUSES WITH USE OF LOCAL HYPERTHERMIA | 2017 |
|
RU2663155C1 |
METHOD OF COMBINATION TREATMENT OF LOCALLY ADVANCED RECTAL CANCER | 2015 |
|
RU2599043C1 |
METHOD OF TREATMENT OF LOCALLY EXTENDED RECTAL CANCER | 2009 |
|
RU2392019C1 |
METHOD FOR TREATING RECTAL CANCER | 2005 |
|
RU2311909C2 |
METHOD OF TREATING RECTAL CANCER | 2011 |
|
RU2477641C1 |
METHOD OF COMBINATION TREATMENT OF LOCALLY ADVANCED RECTAL CANCER | 2010 |
|
RU2447914C1 |
METHOD OF COMBINATION TREATMENT OF OPERABLE NON-SMALL CELL LUNG CANCER STAGE III | 2015 |
|
RU2590866C1 |
METHOD FOR ORGAN-PRESERVING TREATMENT OF OPERABLE RECTAL CANCER | 2020 |
|
RU2740361C1 |
Authors
Dates
2007-08-27—Published
2005-08-26—Filed